Anti-inflammatory and regenerative effects of hypoxic signaling inhibition in a model of COPD

The aim of this study was to investigate anti-inflammatory and regenerative effects of inhibited activation of hypoxic signaling in COPD model using cyclooxygenase-2 (COX-2)-dependent pro-inflammatory cascade inhibition. Methods. COPD was modelled in rats by nitrogen dioxide (NO2, 30-40 mg×m^–3) exposure for 90 days. Celecoxib was used as COX-2 inhibitor. The study group rats were given celecoxib (25 mg×kg^–1) through an esophageal probe after 30 days of exposure. Control rats were given saline solution. The group 3 rats were intact. The rats were put out of the experience using cervical dislocation after 60 and 90 days of NO2 exposure. Bronchoalveolar lavage fluid (BALF) cytology was analyzed. COX-2, hypoxia-inducible factor-1α (HIF-1α), interleukin-17 (IL-17), and surfactant protein D (SP-D) were measured in BALF using ELISA method. Histological examination of the lung tissue was also performed. Results. 90-day exposure of NO2 resulted in 7.7-fold increase in BALF neutrophil count compared to that in intact rats. Pro-inflammatory mediators (СOX-2, HIF-1α, and IL-17) significantly increased and SP-D level decreased in BALF. Administration of celecoxib was accompanied by normalization of BALF cytology profile and decrease in COX-2, HIF-1α, and IL-17 levels in BALF; this could indicate a reduction in the hypoxic signaling activity and in inflammation. The growth of SP-D concentration could be considered as a result of the alveolar epithelium restoration. This was confirmed by histological examination of the lung tissue. Conclusion. COX-2 inhibition suppressed HIF-1α-signaling and decreased the lung inflammation. The results confirm a functional and regulatory relationship between HIF-1α and COX-2 signaling cascades that could be a therapeutic target for preventing the progression of inflammation and airway remodeling in COPD.

chronic obstructive pulmonary disease, inflammation, hypoxia-inducible factor-1α, cyclooxygenase-2, interleukin-17, surfactant protein D, celecoxib

1. Clerici C., Planès C. Gene regulation in the adaptive process to hypoxia in lung epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2009; 296 (3): 267–274. DOI: 10.1152/ajplung.90528.2008.

2. Rey S., Semenza G.L. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc. Res. 2010; 86 (2): 236–242. DOI: 10.1093/cvr/cvq045.

3. Lee S.H., Lee S.H., Kim C.H. et al. Increased expression of vascular endothelial growth factor and hypoxia inducible factor-1α in lung tissue of patients with chronic bronchitis. Clin. Biochem. 2014; 47 (7-8): 552–559. DOI: 10.1016/j.clinbiochem.2014.01.012.

4. Hoenderdos K., Lodge K.M., Hirs R.A. et al. Hypoxia upregulates neutrophil degranulation and potential for tissue injury. Thorax. 2016; 71 (11): 1030–1038. DOI: 10.1136/thoraxjnl-2015-207604.

5. Polke M., Seiler F., Lepper P.M. et al. Hypoxia and the hypoxia-regulated transcription factor HIF-1α suppress the host defence of airway epithelial cells. J. Innate Immun. 2017; 23 (4): 373–380. DOI: 10.1177/1753425917698032.

6. Ito Y., Ahmad A., Kewley E. et al. Hypoxia-inducible factor regulates expression of surfactant protein in alveolar type II cells in vitro. Am. J. Respir. Cell. Mol. Biol. 2011; 45 (5): 938–945. DOI: 10.1165/rcmb.2011-0052OC.

7. Zhong H., Willard M., Simons J. NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms. Int. J. Cancer. 2004; 112 (4): 585–595. DOI: 10.1002/ijc.20438.

8. Bruning U., Fitzpatrick S.F., Frank T. et al. NFκB and HIF display synergistic behaviour during hypoxic inflammation. Cell. Mol. Life Sci. 2012; 69 (8): 1319–1329. DOI: 10.1007/s00018-011-0876-2.

9. Lebedeva E.S., Kuzubova N.A., Danilov L.N., et al. An experimental model of chronic obstructive pulmonary disease. Byulleten’ eksperimental’noy biologii i meditsiny. 2012; 152 (5): 659–663 DOI: 10.1007/s10517-012-1601-3 (in Russian).

10. Gao W., Li L., Wang Y. et al. Bronchial epithelial cells: The key effector cells in the pathogenesis of chronic obstructive pulmonary disease? Respirology. 2015; 20 (5): 722–729. DOI: 10.1111/resp.12542.

11. Yanagisawa H., Hashimoto M., Minagawa S. et al. Role of IL-17A in murine models of COPD airway disease. Am. J. Phisiol. Lung Cell. Mol. Physiol. 2017; 312 (1): 122–130. DOI: 10.1152/ajplung.00301.2016.

12. Lyamina S.V., Malyshev I.Yu. Surfactant protein D in health and in lung diseases. Rossiyskiy meditsinskiy zhurnal. 2012; (1): 50–55 (in Russian).

13. Levänen B., Glader P., Dahlén B. et al. Impact of tobacco smoking on cytokine signaling via interleukin-17A in the peripheral airways. Int. J. Chron. Obstruct. Pulmon. Dis. 2016; 11: 2109–2116. DOI: 10.2147/COPD.S99900.

14. Pappu R., Rutz S., Ouyang W. Regulation of epithelial immunity by IL-17 family cytokines. Trends Immunol. 2012; 33 (7): 343–349. DOI: 10.1016/j.it.2012.02.008.

15. Duan M.C., Zhang J.Q., Liang Y. et al. Infiltration of IL-17-producing T cells and Treg cells in a mouse model of smoke-induced emphysema. Inflammation. 2016; 39 (4): 1334–1344. DOI: 10.1007/s10753-016-0365-8.

16. Yadava K., Bollyky P., Lawson M.A. The formation and function of tertiary lymphoid follicles in chronic pulmonary inflammation. Immunology. 2016; 149 (3): 262–269. DOI: 10.1111/imm.12649.

17. Chen X., Cao J., Chen B.Y. [Interleukin-17 expression and clinical significance in the lung tissue of patients with stable chronic obstructive pulmonary disease]. Zhonghua Yi Xue Za Zhi. 2016; 96 (26): 2086–2090. DOI: 10.3760/cma.j.issn.0376-2491.2016.26.010 (in Chinese).

18. Roos A.B., Sethi S., Nikota J. et al. IL-17A and the promotion of neutrophilia in acute exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2015; 192 (4): 428–437. DOI: 10.1164/rccm.201409-1689OC.

19. Zhang M., Fei X., Zhang G.Q. et al. Role of neutralizing anti-murine interleukin-17A monoclonal antibody on chronic ozone-induced airway inflammation in mice. Biomed. Pharmacother. 2016; 83: 247–256. DOI: 10.1016/j.biopha.2016.06.041.

20. Xu F., Xu Z., Zhang R. et al. Nontypeable Haemophilus influenzae induces COX-2 and PGE2 expression in lung epithelial cells via activation of p38 MAPK and NF-kappa B. Respir. Res. 2008; 9: 16. DOI: 10.1186/1465-9921-9-16.

21. Zago M., Rico de Souza A., Hecht E. et al. The NF-κB family member RelB regulates microRNA miR-146a to suppress cigarette smoke-induced COX-2 protein expression in lung fibroblasts. Toxicol. Lett. 2014; 226 (2): 107–116. DOI: 10.1016/j.toxlet.2014.01.020.

22. Gu W., Song L., Li X.M. et al. Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways. Sci. Rep. 2015; 5: 8733. DOI: 10.1038/srep08733.

23. Sheridan J.A., Zago M., Nair P. et al. Decreased expression of the NF-κB family member RelB in lung fibroblasts from Smokers with and without COPD potentiates cigarette smoke-induced COX-2 expression. Respir. Res. 2015; 16: 54. DOI: 10.1186/s12931-015-0214-6.

24. He X.Y., Shi X.Y., Yuan H.B. et al. Propofol attenuates hypoxia-induced apoptosis in alveolar epithelial type II cells through down-regulating hypoxia-inducible factor-1α. Injury. 2012; 43 (3): 279–283. DOI: 10.1016/j.injury.2011.05.037.

25. Jiang H., Zhu Y.S., Xu H. et al. Inflammatory stimulation and hypoxia cooperatively activate HIF-1(alpha) in bronchial epithelial cells: involvement of PI3K and NF-(kappa)B. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010; 298 (5): 660–669. DOI: 10.1152/ajplung.00394.2009.

26. Lu D., Li N., Yao X., Zhou L. Potential inflammatory markers in obstructive sleep apnea-hypopnea syndrome. Bosn. J. Basic. Med. Sci. 2017; 17 (1): 47–53. DOI: 10.17305/bjbms.2016.1579.

27. Huang M., Wang L., Chen J. et al. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery. Int. J. Oncol. 2016; 48 (5): 2144–2154. DOI: 10.3892/ijo.2016.3421.

28. Eurlings I.M., Reynaert N.L., van den Beucken T. et al. Cigarette smoke extract induces a phenotypic shift in epithelial cells; involvement of HIF1α in mesenchymal transition. PLoS One. 2014; 9 (10): e107757. DOI: 10.1371/journal.pone.0107757.

29. Li H., Wu Q., Xu L. et al. Increased oxidative stress and disrupted small intestinal tight junctions in cigarette smoke-exposed rats. Mol. Med. Rep. 2015; 11 (6): 4639–4644. DOI: 10.3892/mmr.2015.3234.

30. Liu X.H., Kirschenbaum A., Lu M. et al. Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line. J. Biol. Chem. 2002; 277 (51): 50081–50086. DOI: 10.1074/jbc.M201095200.

31. Roh G.S., Yi C.O., Cho Y.J. et al. Anti-inflammatory effects of celecoxib in rat lungs with smoke-induced emphysema. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010; 299 (2): 184–191. DOI: 10.1152/ajplung.00303.2009.